InDi Spinoff Gets $1.5M, Aims to Beat Antibodies in Diagnostics Xconomy Seattle-based InDi, aka Integrated Diagnostics, is planning to graduate from startup mode this year and start selling its first product, a diagnostic test that spots lung cancer in a tiny sample of blood. But before it does that, it has decided to spin ... |
